Advertisements



We are Sorry, This Page doesn't Exist


Shekhar Gupta: Judge thyself too, Your Lordships

The judiciary is under threat from within - from stretching jurisdictions, headline-hunting and its inability to put its own house in order.....»»

Category: topSource: business-standardApr 20th, 2018

Shekhar Gupta: When spies plot peace

Some untold or barely told stories of Indian and Pakistani spymasters making peace on the sidelines of war.....»»

Category: topSource: business-standardMay 25th, 2018

Shekhar Gupta: Because Modiji says so

He's our most polarising leader, deeply hated by many but equally loved by more, especially the young. To extrapolate BJP's struggles in Gujarat and Karnataka to 2019 is being fatally complacent.....»»

Category: topSource: business-standardMay 18th, 2018

Shekhar Gupta: Return of the BJP"s "Iron Men"

Come to Ballari to see the BJP's starkest compromise with organised political crime and corruption yet because of its desperation to win Karnataka.....»»

Category: topSource: business-standardMay 11th, 2018

Shekhar Gupta: Dressing up military history in fatigues

Over the decades, a spiced up, hyper-nationalist version of military history has been built: That politicians wronged the generals. No wonder PM Modi got his facts all mixed up.....»»

Category: topSource: business-standardMay 4th, 2018

Shekhar Gupta: Because freedom can"t be salami-sliced

The media can disagree, fight and judge itself. But it can survive and thrive only by closing ranks when its freedoms are under attack.....»»

Category: topSource: business-standardApr 13th, 2018

Shekhar Gupta: Cracks in the Hindu consensus

BJP overpowered caste divisions to sweep 2014. But the Dalits are angry and the divides are back in play, spelling trouble for the party in 2019.....»»

Category: topSource: business-standardApr 6th, 2018

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Results, Earnings And IPOs

The upcoming week could see some action due to the presence of a host of catalytic events that include PDUFA dates and earnings releases. Here are are the ones a biotech investor should keep a tab on. read more.....»»

Category: blogSource: benzinga10 hr. 33 min. ago

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Results, Earnings And IPOs

The upcoming week could see some action due to the presence of a host of catalytic events that include PDUFA dates and earnings releases. Here are are the ones a biotech investor should keep a tab on. Conferences Alzheimer's Association In.....»»

Category: earningsSource: benzinga10 hr. 48 min. ago

BeiGene announces preliminary topline results of Hodgkin"s Lymphoma trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall11 hr. 33 min. ago

Meet the campaigners who say they will stop at nothing in their quest to break up Facebook

House Judiciary Committee/YouTube Campaign group Freedom from Facebook.....»»

Category: topSource: businessinsiderJul 22nd, 2018

Akorn V. Fresenius - Post Trial Thoughts

Akorn V. Fresenius - Post Trial Thoughts.....»»

Category: topSource: seekingalphaJul 20th, 2018

Experimental treatment uses modified stem cells to fight cancer

Daniel Apodaca is a 25-year-old film student at UCLA. He's also the first patient in a clinical trial that's testing a treatment using genetically modified bone marrow stem cells to fight cancer......»»

Category: videoSource: cnnJul 20th, 2018

4 Biotech Bets to Watch as Industry Rebounds in a Month

The biotech sector makes a sharp rise in 30 days post the positive data read out from Biogen's mid-stage Alzheimer's trial on BAN2401. We recommend a few industry playe.....»»

Category: personnelSource: nytJul 20th, 2018

At patent trial, Groupon casts IBM as shaking down other tech companies

A lawyer for discount e-commerce company Groupon Inc told a court in Delaware on Thursday that International Business Machines Corp has shaken down practically every large tech firm for patent fees......»»

Category: topSource: reutersJul 19th, 2018

Why Is Bernie Sanders" Chief Strategist"s Name All Over Manafort Evidence?

A curious name appeared on an itemized list released on Wednesday of evidence in the trial of former Trump campaign c.....»»

Category: blogSource: zerohedgeJul 19th, 2018

Mersana Therapeutics shares plummet 40% after patient death in cancer trial

Mersana Therapeutics Inc. said early Thursday that, after the company reported a patient death in its cancer drug trial, the Food and Drug Administrat.....»»

Category: topSource: marketwatchJul 19th, 2018

Cara Therapeutics doses first patient in Phase 2 trial of Korsuva for pruritus

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 19th, 2018

Eli Lilly, Boehringer Ingelheim report CARMELINA trial met primary endpoint

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 19th, 2018

Eli Lilly, Boehringer Ingelheim report CARMELINA trial met primary endpoint

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 19th, 2018